Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Best Cytoplan supplements for women in midlife

Research has found that 40 per cent of women over the age of 45 have a chronic health condition

Evening Standard

‘The UK is at the back of the race of turtles’: Sanofi’s boss on the need to develop new medicines

Paul Hudson, the Briton in charge of the French drug firm, is a big believer in the potential of AI to transform healthcare

The Guardian - UK

France could block sale of 'best-selling' drug if production doesn't stay local

France’s Economy Minister has warned that the government could block the sale of a subsidiary of the French pharmaceutical company Sanofi to a US private equity firm if it cannot guarantee that its production of paracetamol, under the name Doliprane, remains in France.

Radio France Internationale

From analysis to the latest developments in health,
read the most diverse news in one place.

Painkiller Sale Plan To US Gives France Major Headache

The planned sale of France's best-selling medical drug to US investors has caused the government a splitting headache after an outcry against the project from politicians on all sides.

International Business Times

There’s an elephant in the room at Keir Starmer’s big investment summit: Brexit

We need a salvage operation to fix the problems this created. Otherwise, how else will we attract global investment, asks Labour MP Stella Creasy

The Guardian - UK

You Could Pay Only $2 for These Drugs Soon Under Medicare

Those enrolled in Medicare could soon pay just $2 for these prescription drugs.

Kiplinger

Politicians’ proposals would only minimally lower US drug prices, says report

Advocates say multiple strategies must be used to lower prices as new drugs threaten to bankrupt health system

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

3 Small-Cap Biotech Stocks to Buy for Major Upside

The biotech industry is flourishing with increasing investments and breakthrough developments. Thus, fundamentally solid small-cap biotech stocks BioCryst Pharmaceuticals (BCRX), Harmony Biosciences (HRMY), and Entrada Therapeutics (TRDA) with potential upside could be worth buying. Read more.

StockNews.com

GSK strikes $2.2bn deal to resolve legal cases in US over heartburn treatment Zantac

British drugmaker agrees payment to resolve 80,000 cases alleging cancers were linked to drug known generically as ranitidine

The Guardian - UK

The ‘huge disadvantage’ women behind femtech phenomenon face

Despite growing demand for female health solutions, businesses are coming up against entrenched prejudice

The Guardian - UK

Activist Starboard Takes $1 Billion Stake In Pfizer, Seeks Former Execs' Support: Reports

Starboard has reached out to former Pfizer CEO Ian Read and ex-finance chief Frank D'Amelio, and both have expressed interest in supporting the activist investor's turnaround efforts, reports said.

International Business Times

CDC Warns Of Dangerous Counterfeit Drugs From Online Pharmacies, Highlighting Overdose Risk

The warning follows last week's U.S. Department of Justice (DOJ) indictment of illegal online pharmacies selling counterfeit prescription pills laced with fentanyl and methamphetamine to tens of thousands of people in the U.S., leading to at least nine deaths.

Medical Daily

3 Healthcare Stocks for Safe, Steady Growth

The healthcare industry is set for growth due to the growing demand for quality healthcare services and ongoing advancements in medical technology. Hence, investors might consider investing in healthcare stocks, Johnson & Johnson (JNJ), AbbVie (ABBV), and Thermo Fisher Scientific (TMO) for safe and steady growth. Read more….

StockNews.com

CVS Health To Eliminate Almost 3,000 Jobs To Cut Costs

The cuts will affect about 1% of its workforce.

International Business Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

‘Pattern of negligence’: a chemical plant fire in Georgia forces tens of thousands to take shelter

The smell of chlorine pervades Conyers as residents say BioLab’s accident was a danger hiding in plain sight

AAP

Pharmacy pill trial becomes 'business as usual'

More ways of expanding health care are being considered amid a GP shortage, with women to continue being able to access contraceptive pills at NSW chemists.

StockNews.com

3 Biotech Stocks Wall Street Predicts Will Skyrocket

Biotech companies could gain the financial flexibility to accelerate their innovations with the Fed’s recent rate cut. To capitalize on this opportunity, consider investing in fundamentally sound biotech stocks Biogen (BIIB), Royalty Pharma (RPRX), and BioMarin Pharmaceutical (BMRN), that are poised to skyrocket. Learn more.

The Independent UK

Nasal spray flu vaccine approved for home use: Here’s what to know

Vaccine provides an alternative to flu shots administered with needles

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

Minister vows 'assertive' approach on vape crackdown

While a ban on vape sales is starting to have an effect, Health Minister Mark Butler says further action is needed on stores that are illegally selling them.

Radio France Internationale

Gavi secures 500,000 doses of mpox vaccine for Africa amid outbreak

The Gavi vaccine alliance has reached an agreement with Danish pharmaceutical company Bavarian Nordic to obtain 500,000 doses of mpox vaccine for African countries dealing with an outbreak of the virus.

The Independent UK

DEA shutting down two offices in China even as agency struggles to stem flow of fentanyl chemicals

The U.S. Drug Enforcement Administration is closing two of its offices in China, a move that comes even as the agency struggles to disrupt the flow of precursor chemicals from the country that have fueled a fentanyl epidemic

The Independent UK

Gilead’s biannual HIV shot reduced risk of infections by 96 percent, company says

The drugmaker said its injections were 89 percent more effective than its own Truvada

Kiplinger

Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.

International Business Times

J&J CEO Slams Biden's Drug Pricing Law, Says It Will 'Chill' Innovation

J&J CEO explained that the new drug-price negotiation law threatens development of new drugs, according to Bloomberg.

The Independent UK

British company deliberately hiked price of life-saving drug, court rules

The NHS was forced to spend over £80m a year on hydrocortisone tablets after the price was rigged

1 … 29 30 31 32

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Department of Justice

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.